1. Home
  2. ASMB vs SES Comparison

ASMB vs SES Comparison

Compare ASMB & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$31.91

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Logo SES AI Corporation

SES

SES AI Corporation

HOLD

Current Price

$1.06

Market Cap

443.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
SES
Founded
2005
2012
Country
United States
United States
Employees
N/A
215
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
442.9M
443.6M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ASMB
SES
Price
$31.91
$1.06
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$44.20
$4.00
AVG Volume (30 Days)
119.5K
10.4M
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$53.90
Revenue Next Year
$638.39
$111.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.13
$0.80
52 Week High
$39.71
$3.73

Technical Indicators

Market Signals
Indicator
ASMB
SES
Relative Strength Index (RSI) 64.78 50.06
Support Level $31.51 $1.00
Resistance Level $32.44 $1.22
Average True Range (ATR) 1.52 0.08
MACD 0.41 0.00
Stochastic Oscillator 99.83 36.67

Price Performance

Historical Comparison
ASMB
SES

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of rechargeable battery technologies and battery materials for Energy Storage Systems (ESS), Urban Air Mobility (UAM), drones, robotics, electric vehicles (EVs), and other applications. For Enery Storage Systems, the company supplies hardware and software solutions with battery health and safety management software powered by its AI-based platform, Molecular Universe. Additionally, it offers battery materials and high-energy and power-density Li-Metal and Li-ion cells, which can be used for drones, UAM, robotics, and EV applications. The company also offers access to Molecular Universe as a software product. Currently, it generates maximum revenue from the development of Li-ion and Li-Metal battery materials as per the client's specifications.

Share on Social Networks: